You are here: Industry Insights > ChAdOx1 nCoV-19

News List

CDSCO grants permission to three private COVID-19 vaccines for restricted use in emergency situation expresspharma
July 21, 2021
The information was given today by Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers, in a written reply in the Lok Sabha.
Oxford University launches Covid-19 vaccine study in children pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
Oxford Covid-19 vaccine doses improve immune response in animals pharmaceutical-technology
June 28, 2020
A study conducted by the Pirbright Institute, in alliance with the University of Oxford, has demonstrated that two doses of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine boost antibody response in pigs, compared to a single dose.
Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax contractpharma
May 29, 2020
The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.
Project leader: Oxford’s COVID-19 vaccine trial has 50 per cent chance of success expresspharma
May 27, 2020
The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus causing the COVID-19 pandemic.
AstraZeneca and Oxford University partner on Covid-19 vaccine pharmaceutical-technology
April 30, 2020
AstraZeneca has signed an agreement with the University of Oxford to develop and distribute the university’s Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
Serum Institute plans to price coronavirus vaccine at ₹1,000 if trials succeed expresspharma
April 29, 2020
The Serum Institute of India announced that it plans this year to produce up to 60 million doses of a potential vaccine against the new coronavirus that is under clinical trial in Britain.
UK COVID-19 vaccine candidate to be manufactured at seven outsourced sites europeanpharmaceuticalreview
April 24, 2020
Following the initiation of a clinical trial, a COVID-19 vaccine candidate developed by UK researchers is being manufactured in several outsourced facilities.
UK COVID-19 vaccine to begin human testing pharmatimes
April 22, 2020
As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths.